IRIS Accounts Production v25.3.0.601 SC304455 Board of Directors 1.8.24 31.7.25 31.7.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC3044552024-07-31SC3044552025-07-31SC3044552024-08-012025-07-31SC3044552023-07-31SC3044552023-08-012024-07-31SC3044552024-07-31SC304455ns15:Scotland2024-08-012025-07-31SC304455ns14:PoundSterling2024-08-012025-07-31SC304455ns10:Director12024-08-012025-07-31SC304455ns10:PrivateLimitedCompanyLtd2024-08-012025-07-31SC304455ns10:SmallEntities2024-08-012025-07-31SC304455ns10:AuditExempt-NoAccountantsReport2024-08-012025-07-31SC304455ns10:SmallCompaniesRegimeForDirectorsReport2024-08-012025-07-31SC304455ns10:SmallCompaniesRegimeForAccounts2024-08-012025-07-31SC304455ns10:FullAccounts2024-08-012025-07-31SC30445512024-08-012025-07-31SC304455ns10:Director22024-08-012025-07-31SC304455ns10:Director32024-08-012025-07-31SC304455ns10:Director42024-08-012025-07-31SC304455ns10:CompanySecretary12024-08-012025-07-31SC304455ns10:RegisteredOffice2024-08-012025-07-31SC304455ns5:CurrentFinancialInstruments2025-07-31SC304455ns5:CurrentFinancialInstruments2024-07-31SC304455ns5:Non-currentFinancialInstruments2025-07-31SC304455ns5:Non-currentFinancialInstruments2024-07-31SC304455ns5:ShareCapital2025-07-31SC304455ns5:ShareCapital2024-07-31SC304455ns5:RetainedEarningsAccumulatedLosses2025-07-31SC304455ns5:RetainedEarningsAccumulatedLosses2024-07-31SC304455ns5:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-31SC304455ns5:PatentsTrademarksLicencesConcessionsSimilar2024-08-012025-07-31SC304455ns5:IntangibleAssetsOtherThanGoodwill2024-07-31SC304455ns5:IntangibleAssetsOtherThanGoodwill2025-07-31SC304455ns5:IntangibleAssetsOtherThanGoodwill2024-07-31SC304455ns5:LandBuildings2024-07-31SC304455ns5:PlantMachinery2024-07-31SC304455ns5:LandBuildings2024-08-012025-07-31SC304455ns5:PlantMachinery2024-08-012025-07-31SC304455ns5:LandBuildings2025-07-31SC304455ns5:PlantMachinery2025-07-31SC304455ns5:LandBuildings2024-07-31SC304455ns5:PlantMachinery2024-07-31SC304455ns5:WithinOneYearns5:CurrentFinancialInstruments2025-07-31SC304455ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-31
REGISTERED NUMBER: SC304455 (Scotland)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST JULY 2025

FOR

ANKERVILLE NURSERY (ALNESS) LTD

ANKERVILLE NURSERY (ALNESS) LTD (REGISTERED NUMBER: SC304455)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST JULY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ANKERVILLE NURSERY (ALNESS) LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST JULY 2025







DIRECTORS: Mrs. C Macrae
D Macrae
Miss F Macrae
Miss C Macrae





SECRETARY: Mr. D Macrae





REGISTERED OFFICE: 10 Knockbreck Street
Tain
Ross-Shire
IV19 1BJ





REGISTERED NUMBER: SC304455 (Scotland)





ACCOUNTANTS: Goldwells Ltd
10 Knockbreck Street
Tain
Ross-Shire
IV19 1BJ

ANKERVILLE NURSERY (ALNESS) LTD (REGISTERED NUMBER: SC304455)

BALANCE SHEET
31ST JULY 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 5,170 5,170
Tangible assets 5 1,160,208 955,917
1,165,378 961,087

CURRENT ASSETS
Debtors 6 207,917 380,559
Cash at bank and in hand 26,056 49,784
233,973 430,343
CREDITORS
Amounts falling due within one year 7 100,438 144,594
NET CURRENT ASSETS 133,535 285,749
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,298,913

1,246,836

CREDITORS
Amounts falling due after more than one
year

8

32,016

25,228
NET ASSETS 1,266,897 1,221,608

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 1,266,895 1,221,606
SHAREHOLDERS' FUNDS 1,266,897 1,221,608

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st July 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st July 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ANKERVILLE NURSERY (ALNESS) LTD (REGISTERED NUMBER: SC304455)

BALANCE SHEET - continued
31ST JULY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21st October 2025 and were signed on its behalf by:





Mrs. C Macrae - Director


ANKERVILLE NURSERY (ALNESS) LTD (REGISTERED NUMBER: SC304455)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST JULY 2025

1. STATUTORY INFORMATION

Ankerville Nursery (Alness) Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 71 (2024 - 76 ) .

ANKERVILLE NURSERY (ALNESS) LTD (REGISTERED NUMBER: SC304455)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST JULY 2025

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1st August 2024
and 31st July 2025 5,170
NET BOOK VALUE
At 31st July 2025 5,170
At 31st July 2024 5,170

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1st August 2024 845,240 329,324 1,174,564
Additions 179,469 67,025 246,494
Disposals - (62,134 ) (62,134 )
At 31st July 2025 1,024,709 334,215 1,358,924
DEPRECIATION
At 1st August 2024 - 218,647 218,647
Charge for year - 42,203 42,203
Eliminated on disposal - (62,134 ) (62,134 )
At 31st July 2025 - 198,716 198,716
NET BOOK VALUE
At 31st July 2025 1,024,709 135,499 1,160,208
At 31st July 2024 845,240 110,677 955,917

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 16,629 11,112
Other debtors 191,288 369,447
207,917 380,559

ANKERVILLE NURSERY (ALNESS) LTD (REGISTERED NUMBER: SC304455)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST JULY 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 15,967 17,039
Hire purchase contracts 11,867 -
Amounts owed to participating interests - 24,164
Taxation and social security 53,039 77,599
Other creditors 19,565 25,792
100,438 144,594

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 11,249 25,228
Hire purchase contracts 20,767 -
32,016 25,228